BACE1 and Alzheimer disease: The concentration and enzymatic activity of BACE1 in the CSF and blood of AD patients are significantly higher than that of control participants, indicating that BACE1 is a promising candidate biological marker of AD (Ewers et al., 2011; Hampel & Shen, 2009; Shen et al., 2018).